Journal of Clinical and Translational Hepatology

Journal of Clinical and Translational Hepatology

Thursday, 05 / 13 / 2021

Articles

Abstract

REVIEW ARTICLE

Progress in the Clinical Features and Pathogenesis of Abnormal Liver Enzymes in Coronavirus Disease 2019

Haiyan Wu# , Shuzhong Liu, Hesheng Luo and Mingkai Chen*

Department of Gastroenterology, Renmin Hospital of Wuhan University, Wuhan, Hubei, China
#These authors contributed equally to this study.
*Correspondence to: Mingkai Chen, Department of Gastroenterology, Renmin Hospital of Wuhan University, 99 Zhangzhidong Road, Wuchang District, Wuhan, Hubei 430060, China. ORCID:  https://orcid.org/0000-0003-2652-6863 . Tel: +86-13720330580, E-mail:  This email address is being protected from spambots. You need JavaScript enabled to view it.

Journal of Clinical and Translational Hepatology 2021;9(2):239-246 DOI: 10.14218/JCTH.2020.00126
Received: November 24, 2020 Accepted: March 28, 2021 Published online: April 25, 2021

Abstract

With the rapid development of research on coronavirus disease 2019 (COVID-19), more and more attention has been drawn to its damage to extrapulmonary organs. There are increasing lines of evidence showing that liver injury is closely related to the severity of COVID-19, which may have an adverse impact on the progression and prognosis of the patients. What is more, severe acute respiratory syndrome coronavirus-2 infection, cytokine storm, ischemia/hypoxia reperfusion injury, aggravation of the primary liver disease and drug-induced liver injury may all contribute to the hepatic damage in COVID-19 patients; although, the drug-induced liver injury, especially idiosyncratic drug-induced liver injury, requires further causality confirmation by the updated Roussel Uclaf Causality Assessment Method published in 2016. Up to now, there is no specific regimen for COVID-19, and COVID-19-related liver injury is mainly controlled by symptomatic and supportive treatment. Here, we review the clinical features of abnormal liver enzymes in COVID-19 and pathogenesis of COVID-19-related liver injury based on the current evidence, which may provide help for clinicians and researchers in exploring the pathogenesis and developing treatment strategies.

Keywords

Coronavirus disease 2019, Abnormal liver enzymes, Liver injury, Idiosyncratic drug-induced liver injury, Roussel Uclaf Causality Assessment Method, Clinical characteristics

Journal of Clinical and Translational Hepatology 2021 vol. 9, 227-238  [ Html  ] [ PDF Full-text ]

© 2021 Authors. This is an Open Access article distributed under the terms of the  Creative Commons Attribution-Noncommercial 4.0 License(CC BY-NC 4.0), permitting all non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.

 logo

You are here: Home